Leptospirosis case report form by Centers for Disease Control and Prevention (U.S.)
Public reporting burden of this collection of information is estimated to average 15 minutes per response, including the time for reviewing instructions, searching existing data sources, gathering and maintaining the data needed, and 
completing and reviewing the collection of information. An agency may not conduct or sponsor, and a person is not required to respond to a collection of information unless it displays a currently valid OMB control number. Send 
comments regarding this burden estimate or any other aspect of this collection of information, including suggestions for reducing this burden to CDC/ATSDR Information Collection Review Oce, 1600 Clifton Road NE, MS D-74, 
Atlanta, Georgia 30329-4027; ATTN: PRA (0920-0728).
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Leptospirosis Case Report Form
Visit www.cdc.gov/leptospirosis for a llable PDF version of this Case Report
Form Approved 
OMB 0920-0728 
Exp. 1/31/2019
Patient’s Name: Date First Submitted: Clinician’s Name: 
Address: State Case ID: Clinician’s Phone: 
City: Reporting State: 
Demographics
Clinical Presentation
Outcome
Laboratory Results
State of Residence Zip Code County of Usual Residence Sex
 Male   Female
 Unknown
Pregnant
 Yes   No
 Unknown
Birth Date Age  days
 months
 years
Race
 Alaska Native or American Indian    Black/African American                                White
 Asian                                                Native Hawaiian or Other Pacic Islander    Not Specied
Ethnicity
 Hispanic or Latino   Not Hispanic or Latino
 Unknown
Was the patient symptomatic?   Yes   No   Unknown If yes, Date of Onset 
Select all clinical manifestations the patient experienced:
 Fever
 Myalgia
 Headache 
 Conjunctival suusion
 Thrombocytopenia 
 Aseptic meningitis
 Jaundice
 Hepatitis
 Hemorrhage 
 Pulmonary complications
 Cardiac involvement
 Renal insuciency/failure 
 Gastrointestinal involvement
 Rash (petechial or maculopapular)
 Other, specify: 
Was the patient hospitalized?  Yes   No   Unknown If yes, date admitted Number of days hospitalized 
Was antimicrobial treatment given for this infection?   Yes   No   Unknown If yes, date started 
Which drugs (select all that apply)?  Doxycycline    Penicillin    Other, specify: 
Clinical Outcome:   Still hospitalized    Died    Discharged    Other
Date of Discharge    Date of Death    Illness Duration (days) 
Culture Specimen Type
 Blood     CSF         Other 
 Urine      Tissue      Unknown
Collection date Result
 Positive       Unknown
 Negative     
PCR Specimen Type
 Blood     CSF         Unknown
 Urine      Other 
Collection date Result
 Positive       Unknown
 Negative    
PCR Specimen Type
 Blood     CSF         Unknown
 Urine      Other 
Collection date Result
 Positive       Unknown
 Negative     
MAT Acute Convalescent (≥ 2 weeks later)                     4-fold rise in titer
Collection Date  
Highest Titer 
Collection Date    
Highest Titer 
 Single titer ≥ 800
Other test  ELISA     Immunohistochemistry (IHC)    Lateral ow test
 Other (Specify): 
Result
 Positive    Negative     Unknown
 Inconclusive
Titer*  *If applicable
If ELISA, 
choose type  IgG    IgM    IgG & IgM    ImmunoDot (IgM)    Not Applicable
Leptospira serovar^ ^identied by PFGE, MLST, or other molecular typing method
Redact Patient’s Name and Address prior to sending a copy of the form to CDC. 
Send completed form by fax to (404) 929-1590, encrypted email to bspb@cdc.gov, secure FTP, or to CDC / Bacterial Special Pathogens Branch, 1600 Clifton Road NE, MS-A30, 
Atlanta, GA 30329-4027. Call (404) 639-1711 or email bspb@cdc.gov with questions about a case, lab testing, or form submission.
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Confirmed: Isolation of Leptospira from a clinical specimen, OR fourfold or greater increase in Leptospira agglutination titer between acute- and convalescent-phase serum specimens 
studied at the same laboratory, OR demonstration of Leptospira in tissue by direct immunofluorescence, OR Leptospira agglutination titer of ≥ 800 by Microscopic Agglutination Test 
(MAT) in one or more serum specimens, OR detection of pathogenic Leptospira DNA (e.g., by PCR) from a clinical specimen.
Probable: A clinically compatible case with involvement in an exposure event (e.g., adventure race, triathlon, flooding) with known associated cases, OR Leptospira agglutination 
titer of ≥ 200 but < 800 by Microscopic Agglutination Test (MAT) in one or more serum specimens, OR demonstration of anti-Leptospira antibodies in a clinical specimen by indirect 
immunofluorescence, OR demonstration of Leptospira in a clinical specimen by darkfield microscopy, OR detection of IgM antibodies against Leptospira in an in acute phase serum 
specimen, but without confirmatory laboratory evidence of Leptospira infection.
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Contact with 
animals 
(select all that apply)
 Farm livestock      Wildlife      Rodents      Dogs      Other      No known contact      Unknown
Specify animal: 
Where did animal contact(s) occur (eg, at home)? 
Contact with 
water 
(select all that apply)
 Standing fresh water (eg, lake, pond)      River/stream      Wet soil      Flood water, run-off      Sewage
 Other      No known contact      Unknown     Specify water: 
Where did water contact(s) occur (specify location)? 
If the patient had contact with animals or water, select the type of contact:
In the 30 days prior to illness onset,
Classify case based on the CSTE/CDC case definition (see criteria below) 
Comments
 Occupational 
 Farmer (Land)      Farmer (Animals)      Fish worker      Unknown      Other
If Other, Specify: 
 Avocational
 Gardening      Pet Ownership      Unknown      Other
If Other, Specify: 
 Recreational
 Swimming      Boating      Outdoor competition     Camping/hiking      Hunting      Unknown      Other
If Other, Specify: 
 Other (Specify):
Did the patient stay in housing with evidence of rodents?    Yes   No   Unknown Did the patient stay in a rural area?    Yes   No   Unknown
Did the patient travel outside of county, state, or country?   Yes   No   Unknown Travel destination(s): 
Was there heavy rainfall near the patient’s place of residence, work site, activities, or travel?    Yes   No   Unknown
Was there flooding near the patient’s place of residence, work site, activities, or travel?    Yes   No   Unknown
Did the patient have similar exposures as a contact diagnosed with leptospirosis in the 30 day period?    Yes   No   Unknown
Has the patient ever had leptospirosis?    Yes   No   Unknown         Is this patient part of an outbreak?    Yes   No   Unknown
If yes, describe outbreak: 
 Confirmed     Probable
Investigator Name: Phone Number: 
Exposures in 30 days prior to illness onset, specify if the patient had:
